Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Liver Neoplasms 2Neoplasm Metastasis 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 642pembrolizumab 565Magnetic Resonance Spectroscopy 548Carboplatin 426Cisplatin 377Cyclophosphamide 374Biopsy 365Paclitaxel 306Nivolumab 303Gemcitabine 303Radiotherapy 274Bevacizumab 240Dexamethasone 209fludarabine 207Docetaxel 191durvalumab 183atezolizumab 177Oxaliplatin 174venetoclax 168Fluorouracil 167Rituximab 166Pemetrexed 164Capecitabine 161Radiation 159Doxorubicin 159Radiosurgery 150Etoposide 137Ipilimumab 135Leucovorin 133Lenalidomide 132

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Hepatectomy × 90 days × Clear all
NCT07587216 2026-06-04

Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment

Tongji Hospital

Recruiting
800 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis

NCT07612007 2026-06-01

HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization

Mayo Clinic

Phase 2 Not yet recruiting
80 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04597710 2026-05-29

Precision1

Perspectum

Completed
200 enrolled
Gastrointestinal

Liver Neoplasms

NCT07581769 2026-05-14

Radiomics Subtyping to Guide Surgery vs. Maintenance Therapy After HCC Downstaging

First Affiliated Hospital, Sun Yat-Sen University

Active not recruiting
500 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡